Antiplatelet medications used to prevent or treat thrombotic complications in cerebrovascular stent patients
| Medication | Routinely used (No (%)) | Ever used (No (%)) |
|---|---|---|
| Clopidogrel (Plavix) | 61 (93.8) | 62 (95.4) |
| Aspirin 325 mg (Ecotrin) | 53 (81.5) | 59 (90.8) |
| Aspirin 81 mg (Ecotrin) | 21 (32.3) | 50 (76.9) |
| Abciximab (ReoPro) | 14 (21.9) | 54 (83.1) |
| Eptifibatide (Integrilin) | 8 (12.5) | 28 (43.1) |
| Prasugrel (Effient) | 7 (10.8) | 30 (46.2) |
| Tirofiban (Aggrastat) | 4 (6.2) | 12 (18.5) |
| Ticlopidine (Ticlid) | 2 (3.1) | 35 (53.8) |
| Dipyridamole (Persantine) | 2 (3.1) | 14 (21.5) |
| Other* | 2 (3.1) | 7 (10.8) |
| Ibuprofen (Advil) | 0 (0.0) | 5 (7.7) |
| *Other | Ticagrelor (Brilinta) (n=1) Heparin (Heparin) (n=1) | Ticagrelor (Brilinta) (n=3) Pletal (Cilostazol) (n=2) Heparin (Heparin) (n=1) Aspirin/dipyridamole (Aggrenox) (n=1) |